ACTU
Actuate Therapeutics IncNASDAQHealthcare$2.48-0.40%ClosedMarket Cap: $58.8M
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
6.16
P/S
0.00
EV/EBITDA
-1.66
DCF Value
$0.54
FCF Yield
-38.9%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-799.6%
ROA
-158.4%
ROIC
-270.1%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $0.00 | NaN% | $-4.7M | $-4.6M | $-0.20 | — |
| FY 2025 | $0.00 | NaN% | $-22.5M | $-22.2M | $-1.06 | — |
| Q3 2025 | $0.00 | NaN% | $-5.5M | $-5.4M | $-0.25 | — |
| Q2 2025 | $0.00 | NaN% | $-6.0M | $-5.9M | $-0.30 | — |
| Q1 2025 | $0.00 | NaN% | $-6.4M | $-6.3M | $-0.32 | — |
| Q4 2024 | $0.00 | NaN% | $-6.6M | $-6.4M | $-0.60 | — |
| FY 2024 | $0.00 | NaN% | $-25.2M | $-27.3M | $-3.26 | — |
| Q3 2024 | $0.00 | NaN% | $-5.4M | $-6.0M | $-0.55 | — |
| Q2 2024 | $0.00 | NaN% | $-5.4M | $-6.6M | $-0.34 | — |
| Q1 2024 | $0.00 | NaN% | $-7.8M | $-8.3M | $-0.54 | — |
| Q4 2023 | $0.00 | NaN% | $-7.6M | $-7.6M | $-0.50 | — |
| FY 2023 | $0.00 | NaN% | $-25.0M | $-24.7M | $-1.65 | — |